# Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside

## TL;DR

This review explores how non-coding RNAs could serve as biomarkers or treatment targets for peritoneal carcinomatosis, an advanced and deadly form of cancer.

## Contribution

The paper provides a comprehensive overview of non-coding RNA changes in peritoneal carcinomatosis, highlighting their potential as biomarkers and therapeutic targets.

## Key findings

- Non-coding RNAs show significant changes in peritoneal carcinomatosis, indicating their regulatory role in the disease.
- Altered non-coding RNA levels are linked to cancer progression and could be used for early detection or treatment.
- The review identifies gaps in research and suggests future directions for studying non-coding RNAs in this condition.

## Abstract

Peritoneal carcinomatosis is a term for cancer cells spreading from tumors of internal organs and massively invading a large part of the membrane lining the abdomen and pelvis. For most patients, peritoneal carcinomatosis suggests only several months of life left. Current medicine can offer only alleviation of symptoms from this incurable disease. Researchers are intensely exploring some new therapeutic targets. Among promising candidates are non-coding RNAs, short molecules serving as important regulators in cells. When a disease such as cancer develops in the body, it is accompanied by typical changes in levels of non-coding RNAs. In this review, we provide an overview of current state of knowledge regarding the changes of non-coding RNA levels in peritoneal carcinomatosis. Deeper understanding of this topic could lead to the identification of non-coding RNAs as feasible specific biomarkers or novel therapeutic targets in the treatment of peritoneal carcinomatosis.

Peritoneal carcinomatosis represents an advanced stage of tumors within the peritoneal cavity. Once considered an incurable terminal cancer metastasis, contemporary medicine is on the hunt for certain potentially curative options alongside the present day’s palliative disease management. However, for most patients, peritoneal carcinomatosis continues to pose a fatal late-stage prognosis with a grim future outlook. Over the past two decades, non-coding RNAs have garnered significant attention due to their undeniable significance in regulating cellular processes across all levels. Disruption of the intricate regulation led by non-coding RNAs has been demonstrated to have a substantial impact on various human diseases, particularly in cancer, including solid tumors originating from the organs of the peritoneal cavity. This review aims to offer a comprehensive overview of the current state of knowledge in the under-researched field of peritoneal carcinomatosis, focusing specifically on the role of non-coding RNAs in the development of this condition and delineating potential avenues for future research.